Analysis of sparse data in pharmacokinetic studies
Open Access
- 1 December 2020
- journal article
- Published by Publishing House OKI in Pharmacokinetics and Pharmacodynamics
- No. 2,p. 28-33
- https://doi.org/10.37489/2587-7836-2020-2-28-33
Abstract
Performing pharmacokinetic and statistical analysis in the case of sparse data presents significant difficulties. Using the example of the pharmacokinetic (PK) study of resveratrol in mice, the resampling method was allowed us to obtain individual PK-parameters and perform full-fledged statistical tests.Keywords
This publication has 7 references indexed in Scilit:
- Pharmacokinetic parameters of ifosfamide in mouse pre-administered with grapefruit juice or naringinScientific Reports, 2019
- Capillary microsampling in mice: effective way to move from sparse sampling to serial sampling in pharmacokinetics profilingXenobiotica, 2019
- Cerebrospinal fluid pharmacokinetics of ceftaroline in neurosurgical patients with an external ventricular drainJournal of Antimicrobial Chemotherapy, 2018
- Naive Pooled–Data Approach for Pharmacokinetic Studies in Pediatrics With a Very Small Sample SizeClinical Journal of Sport Medicine, 2014
- Bayesian approach to estimate AUC, partition coefficient and drug targeting index for studies with serial sacrifice design.Pharmaceutical Research, 2013
- Non-compartmental AnalysisPublished by Springer Science and Business Media LLC ,2012
- A random sampling approach for robust estimation of tissue-to-plasma ratio from extremely sparse dataThe AAPS Journal, 2005